Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma

Glioblastomas (GBM) are highly invasive, malignant primary brain tumors. The overall prognosis is poor, and management of GBMs remains a formidable challenge, necessitating novel therapeutic strategies such as dendritic cell vaccinations (DCVs). While many early clinical trials demonstrate an induct...

Descripción completa

Detalles Bibliográficos
Autores principales: Subtirelu, Robert C., Teichner, Eric M., Ashok, Arjun, Parikh, Chitra, Talasila, Sahithi, Matache, Irina-Mihaela, Alnemri, Ahab G., Anderson, Victoria, Shahid, Osmaan, Mannam, Sricharvi, Lee, Andrew, Werner, Thomas, Revheim, Mona-Elisabeth, Alavi, Abass
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644823/
https://www.ncbi.nlm.nih.gov/pubmed/38020665
http://dx.doi.org/10.3389/fneur.2023.1271822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644823/
https://www.ncbi.nlm.nih.gov/pubmed/38020665
http://dx.doi.org/10.3389/fneur.2023.1271822

Ejemplares similares